Express Pharma
Close the sidebar
Express Pharma
Browsing tag
Establishment Inspection Report (EIR)
US FDA issues EIR for Lupin’s injectable facility in Nagpur
Read more
USFDA classifies inspection at Dr Reddy’s API facility as Voluntary Action Indicated
Read more
Lupin receives US FDA Establishment Inspection Report for Somerset facility
Read more
Axxelent receives its first US FDA Establishment Inspection Report (EIR)
Read more
Aurobindo Pharma gets EIR with VAI status from USFDA for Hyderabad facility
Read more
Strides arm receives EIR for its US facility
Read more
Cipla announces closure of USFDA inspection at Patalganga facility
Read more
